We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$3.77B
AUM Growth
+$720M
Cap. Flow
+$280M
Cap. Flow %
7.43%
Top 10 Hldgs %
22.38%
Holding
294
New
116
Increased
45
Reduced
52
Closed
77

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$115M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$93.9M
3
NXPI icon
NXP Semiconductors
NXPI
+$57.1M
4
LLY icon
Eli Lilly
LLY
+$51.1M
5
QRVO icon
Qorvo
QRVO
+$47.7M

Top Sells

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$72.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$66.5M
3
AMZN icon
Amazon
AMZN
+$65.6M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$58.8M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$53.4M

Sector Composition

Rank Sector Weight
1 Healthcare 42.9%
2 Technology 32.83%
3 Communication Services 8.98%
4 Financials 3.92%
5 Consumer Discretionary 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
276
Zymeworks
ZYME
$1.71B
– –
-415,895
Closed -$19.4M
INFN
277
DELISTED
Infinera Corporation Common Stock
INFN
– –
-1,001,608
Closed -$6.17M
SUMO
278
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
– –
-165,000
Closed -$3.6M
ATNX
279
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-25,000
Closed -$6.05M
AKUS
280
DELISTED
Akouos Inc
AKUS
– –
-325,831
Closed -$7.45M
CVET
281
DELISTED
Covetrus, Inc. Common Stock
CVET
– –
-226,378
Closed -$5.52M
LEAP.U
282
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
– –
-516,400
Closed -$6.71M
XLRN
283
DELISTED
Acceleron Pharma
XLRN
– –
-90,534
Closed -$10.2M
BOWXU
284
DELISTED
BowX Acquisition Corp. Unit
BOWXU
– –
-800,000
Closed -$8.21M
RTP.U
285
DELISTED
Reinvent Technology Partners Units, each consisting of one Class A ordinary share and one-fourth of
RTP.U
– –
-1,150,000
Closed -$13.2M
DGNR.U
286
DELISTED
Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f
DGNR.U
– –
-1,847,783
Closed -$22.6M
ALXN
287
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-466,572
Closed -$53.4M
GWPH
288
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-90,435
Closed -$8.8M
DMYD.U
289
DELISTED
dMY Technology Group, Inc. II Units, each consisting of one share of Class A common stock and one-th
DMYD.U
– –
-1,240,000
Closed -$12.7M
IPHI
290
DELISTED
INPHI CORPORATION
IPHI
– –
-217,150
Closed -$24.4M
PAND
291
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
– –
-75,101
Closed -$861K
PRVL
292
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
– –
-385,480
Closed -$3.92M
BMY.RT
293
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$0 ﹤0.01%
902,102
+755,183
+514% +$1.61M
MYOK
294
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-16,736
Closed -$2.28M
8 9 10 11
12

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Woodline Partners held 294 positions worth $3.77B, up 24% from $3.05B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Woodline Partners deployed $280M of net new capital in Q4 2020, opening 116 new positions and adding to 45 existing holdings. Its largest new stake was Amgen: 500,520 shares worth $115M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $58.8M trimmed.

  • Woodline Partners's largest Q4 2020 buy was Amgen: 500,520 shares worth $115M.
  • Woodline Partners added most to Eli Lilly in Q4 2020, an estimated $51.1M increase.
  • Woodline Partners's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $58.8M.
  • Woodline Partners fully exited Microchip Technology in Q4 2020, selling an estimated $72.6M.
  • Woodline Partners's ten largest holdings make up 22% of its $3.77B portfolio in Q4 2020.
  • Woodline Partners opened 116 new positions and closed 77 in Q4 2020.
  • Woodline Partners's portfolio value rose 24% quarter-over-quarter to $3.77B.

Based on Woodline Partners's 13F filing for Q4 2020, filed 16 Feb 2021.